Literature DB >> 20340003

Alteration of angiogenic patterns on B16BL6 melanoma development promoted in Matrigel.

Shuji Kitahara1, Shunichi Morikawa, Kazuhiko Shimizu, Hiroyuki Abe, Taichi Ezaki.   

Abstract

Because the progression and metastasis of solid tumors depend on their local microcirculation, we sought to characterize tumor angiogenesis three dimensionally in a highly metastatic mouse melanoma model, B16BL6 (B16), injected with Matrigel into the subcutis in the skin on the back of syngeneic C57BL/6 mice. We found that B16 with Matrigel grew significantly faster than B16 alone and had altered tumor angiogenesis. Tumor vessels apparently grew vigorously in the opposite direction of the tumor without invading the tumor mass until at least day 10 of injection. In addition, vascular branching resulted not only from sprouting as was seen in B16 without Matrigel but also from vascular splitting, either because of compression from outside the vessels or from septum formation by endothelial cells. This phenomenon was characteristic of B16 cells, but not of other tumor cells, including Lewis lung carcinoma and ASH-1 hybridoma cell lines, both of which were tested under the same conditions. The reduction in various angiogenic factors in Matrigel did not affect the angiogenic patterns and tumor growth. We hypothesize that tumor vessels may vigorously alter their angiogenic patterns in response to the local microenvironment.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20340003     DOI: 10.1007/s00795-009-0481-8

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  39 in total

1.  Genes expressed in human tumor endothelium.

Authors:  B St Croix; C Rago; V Velculescu; G Traverso; K E Romans; E Montgomery; A Lal; G J Riggins; C Lengauer; B Vogelstein; K W Kinzler
Journal:  Science       Date:  2000-08-18       Impact factor: 47.728

2.  Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin.

Authors:  Y Maeshima; M Manfredi; C Reimer; K A Holthaus; H Hopfer; B R Chandamuri; S Kharbanda; R Kalluri
Journal:  J Biol Chem       Date:  2001-02-07       Impact factor: 5.157

Review 3.  Angiogenesis and vascular remodeling by intussusception: from form to function.

Authors:  Haymo Kurz; Peter H Burri; Valentin G Djonov
Journal:  News Physiol Sci       Date:  2003-04

Review 4.  CD 105 and angiogenesis.

Authors:  P Kumar; J M Wang; C Bernabeu
Journal:  J Pathol       Date:  1996-04       Impact factor: 7.996

5.  Anti-angiogenic cues from vascular basement membrane collagen.

Authors:  P C Colorado; A Torre; G Kamphaus; Y Maeshima; H Hopfer; K Takahashi; R Volk; E D Zamborsky; S Herman; P K Sarkar; M B Ericksen; M Dhanabal; M Simons; M Post; D W Kufe; R R Weichselbaum; V P Sukhatme; R Kalluri
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

Review 6.  Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.

Authors:  Rakesh K Jain
Journal:  Science       Date:  2005-01-07       Impact factor: 47.728

7.  Permeability-related changes revealed at endothelial cell borders in inflamed venules by lectin binding.

Authors:  G Thurston; P Baluk; A Hirata; D M McDonald
Journal:  Am J Physiol       Date:  1996-12

8.  Openings between defective endothelial cells explain tumor vessel leakiness.

Authors:  H Hashizume; P Baluk; S Morikawa; J W McLean; G Thurston; S Roberge; R K Jain; D M McDonald
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

9.  Cancer biology. All in the stroma: cancer's Cosa Nostra.

Authors:  Jean Marx
Journal:  Science       Date:  2008-04-04       Impact factor: 47.728

10.  Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity.

Authors:  Olivier Peyruchaud; Claire-Marie Serre; Roisin NicAmhlaoibh; Pierrick Fournier; Philippe Clezardin
Journal:  J Biol Chem       Date:  2003-09-03       Impact factor: 5.157

View more
  5 in total

1.  Distinctive role of vasohibin-1A and its splicing variant vasohibin-1B in tumor angiogenesis.

Authors:  S Horie; Y Suzuki; M Kobayashi; T Kadonosono; S Kondoh; T Kodama; Y Sato
Journal:  Cancer Gene Ther       Date:  2016-04-15       Impact factor: 5.987

2.  Study in vivo intraocular biocompatibility of in situ gelation hydrogels: poly(2-ethyl oxazoline)-block-poly(ε-caprolactone)-block-poly(2-ethyl oxazoline) copolymer, matrigel and pluronic F127.

Authors:  Yih-Shiou Hwang; Ping-Ray Chiang; Wei-Hsin Hong; Chuan-Chin Chiao; I-Ming Chu; Ging-Ho Hsiue; Chia-Rui Shen
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

3.  Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis.

Authors:  Taisuke Kawamoto; Noritaka Ohga; Kosuke Akiyama; Naoya Hirata; Shuji Kitahara; Nako Maishi; Takahiro Osawa; Kazuyuki Yamamoto; Miyako Kondoh; Masanobu Shindoh; Yasuhiro Hida; Kyoko Hida
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

4.  Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis.

Authors:  Shuji Kitahara; Yasuhiro Suzuki; Masae Morishima; Asuka Yoshii; Sachiko Kikuta; Kazuhiko Shimizu; Shunichi Morikawa; Yasufumi Sato; Taichi Ezaki
Journal:  Mol Cancer       Date:  2014-05-04       Impact factor: 27.401

5.  Role of the vasohibin family in the regulation of fetoplacental vascularization and syncytiotrophoblast formation.

Authors:  Kaori Suenaga; Shuji Kitahara; Yasuhiro Suzuki; Miho Kobayashi; Sachiko Horie; Junichi Sugawara; Nobuo Yaegashi; Yasufumi Sato
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.